Health8/25/2025The Guardian

Wes Streeting criticises ‘shortsighted’ drug firms for rejecting pricing offer

Wes Streeting criticises ‘shortsighted’ drug firms for rejecting pricing offer

The article discusses a row between Wes Streeting, the UK Health Secretary, and pharmaceutical companies over the pricing of their products. Streeting has accused drug firms of being "shortsighted" and rejecting the government's pricing offer, which he claims would prevent patients from being "ripped off." The standoff between the government and the pharmaceutical industry has not been resolved, and Streeting has vowed not to let the industry take advantage of British patients or taxpayers. The article suggests that the dispute is ongoing and that the Health Secretary is determined to find a solution that protects the interests of the public.

Source: For the complete article, please visit the original source link below.

Related Articles

Peter Mandelson sacked for saying Epstein’s first conviction was wrong, minister says – UK politics live
🏥 Health5h ago1 min read

Peter Mandelson sacked for saying Epstein’s first conviction was wrong, minister says – UK politics live

Michel Odent obituary
🏥 Health5h ago1 min read

Michel Odent obituary

Doctor’s ‘dangerous’ vaccine claims at Reform UK conference to be examined by GMC
🏥 Health5h ago1 min read

Doctor’s ‘dangerous’ vaccine claims at Reform UK conference to be examined by GMC

‘Our hallway’s big enough to play football in!’ The council housing that feels like a holiday resort
🏥 Health6h ago1 min read

‘Our hallway’s big enough to play football in!’ The council housing that feels like a holiday resort

‘The chaos is the point’: tumult as Covid vaccine boosters deployed under RFK Jr
🏥 Health7h ago1 min read

‘The chaos is the point’: tumult as Covid vaccine boosters deployed under RFK Jr

Girls who play after-school sport in UK 50% more likely to later get top jobs, study finds
🏥 Health10h ago1 min read

Girls who play after-school sport in UK 50% more likely to later get top jobs, study finds